Produkty 2099-26-5

CAS 2099-26-5 występuje w naszej ofercie pod nazwami: Androstenediol Diacetate, Androst–5–ene–3β，17β–diol 3，17–diacetate. Oferty producentów: TRC, GLPBio, Biosynth. Dostępne opakowania: 2,5g, 250mg, 500mg, 5mg, 50mg, 100mg.

Androstenediol Diacetate
TRC, Biosynth
  • opakowanie: 2,5g, 250mg, 500mg, 50mg
  • Warianty: 7
Zobacz produkt
Androst–5–ene–3β，17β–diol 3，17–diacetate
GLPBio
  • opakowanie: 5mg
  • Warianty: 1
od 559,60
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

[(3S,8R,9S,10R,13S,14S,17S)-17-acetyloxy-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate (CAS 2099-26-5) to związek chemiczny o wzorze sumarycznym C23H34O4 i masie molowej 374.5 g/mol. Nazwa systematyczna IUPAC: [(3S,8R,9S,10R,13S,14S,17S)-17-acetyloxy-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate. InChIKey: QXKRUGDXPWHXHL-FQJIPJFPSA-N.

Dane identyfikacyjne
Wzór sumarycznyC23H34O4
Masa molowa374.5 g/mol
Nazwa IUPAC[(3S,8R,9S,10R,13S,14S,17S)-17-acetyloxy-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate
InChIKeyQXKRUGDXPWHXHL-FQJIPJFPSA-N
SMILESCC(=O)O[C@H]1CC[C@@]2([C@H]3CC[C@]4([C@H]([C@@H]3CC=C2C1)CC[C@@H]4OC(=O)C)C)C

Dane obliczone przez PubChem (NCBI)

Synonimy: Androstenediol diacetate, Androst-5-ene-3beta,17beta-diol 3,17-diacetate, Androst-5-ene-3,17-diol, 3,17-diacetate, (3beta,17beta)-, Androstenediol 3,17-diacetate, 3beta,17betadiacetoxyandrost-5-ene, 3beta,17beta diacetoxyandrost-5-ene, 5-Isoandrosten-3,17-diol diacetate, ANDROSTENEDIOL DIACETATE [MI], 3beta,17beta-diacetoxy-androst-5-en, 3beta,17beta- diacetoxyandrost-5-ene
Izomery (ten sam wzór sumaryczny)
3-[(3R,5S,10S,13R,14S,17R)-3,14-dihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2H-furan-5-one C23H34O4
3-[(3S,5R,8R,9S,10S,13R,14S,17R)-3,14-dihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2H-furan-5-one C23H34O4
(3aS,9aS,9bS)-3a-methyl-6-[2-(2,5,5-trimethyl-1,3-dioxan-2-yl)ethyl]-1,2,4,5,8,9,9a,9b-octahydrocyclopenta[a]naphthalene-3,7-dione C23H34O4
(3R)-3-[(1R,3aS,4E,7aR)-4-[(2Z)-2-[(3S,5R)-3,5-dihydroxy-2-methylidenecyclohexylidene]ethylidene]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-1-yl]butanoic acid C23H34O4
[(1R)-1-[(8R,9S,10R,13S,14S,17R)-17-hydroxy-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl]ethyl] acetate C23H34O4
[(8R,9S,10R,13S,14S,17R)-17-[(1S)-1-hydroxyethyl]-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate C23H34O4
(1R,2S,4R,6S,7S,10S,11R,14S)-7,11-dimethyl-6-(2-methyl-1,3-dioxolan-2-yl)-5-oxapentacyclo[8.8.0.02,7.04,6.011,16]octadec-16-en-14-ol C23H34O4
10-ethoxy-6,6,9-trimethyl-3-pentyl-8,10-dihydro-7H-benzo[c]chromene-1,9-diol C23H34O4
[(3S,8R,9S,10R,13S,14S,17R)-17-acetyl-3-hydroxy-10,13-dimethyl-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate C23H34O4
[2-[(3S,8S,9S,10R,13S,14S,17S)-3-hydroxy-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate C23H34O4